acetylcysteine has been researched along with MODS in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (25.00) | 18.2507 |
| 2000's | 12 (42.86) | 29.6817 |
| 2010's | 7 (25.00) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 1 |
| Basile, K; Colaco, CMG; Draper, J; Ferguson, PE | 1 |
| Koch, A; Streetz, KL; Tacke, F; Trautwein, C | 1 |
| Bedreag, OH; Cradigati, CA; Dumache, R; Horhat, FG; Luca, L; Papurica, M; Popovici, SE; Rogobete, AF; Sandesc, D; Sarandan, M; Sima, LV; Vernic, C | 1 |
| Chertoff, J | 1 |
| Kramer, DJ; Stravitz, RT | 1 |
| Hou, L; Ji, G; Li, N; Li, S; Lu, Y; Ma, S; Peng, D; Qin, M; Shang, L; Xie, K; Xiong, L | 1 |
| Andrades, M; Dal-Pizzol, F; de Oliveira, MR; Fonseca Moreira, JC; Ritter, C; Streck, EL | 1 |
| Bogar, L; Bognar, Z; Csontos, C; Drenkovics, L; Foldi, V; Lantos, J; Rezman, B; Röth, E; Weber, G | 1 |
| Bogar, L; Csontos, C; Drenkovics, L; Foldi, V; Lantos, J; Rezman, B; Röth, E; Weber, G | 1 |
| Márton, S; Molnár, Z; Szakmány, T; Tóth, I | 1 |
| Koszegi, T; Molnar, Z; Szakmany, T | 1 |
| Marton, S; Molnar, Z; Szakmany, T | 1 |
| Baue, AE | 1 |
| Asfar, P; De Backer, D; Meier-Hellmann, A; Radermacher, P; Sakka, SG | 1 |
| Diltoer, MW; Hendrickx, I; Huyghens, LP; Nguyen, DN; Spapen, HD | 1 |
| Akinci, SB; Aypar, U; Erden, IA; Kanbak, M | 1 |
| Chen, HI; Harn, HJ; Hsu, BG; Lee, RP; Yang, FL | 1 |
| Bewley, J; Bourdeaux, C | 1 |
| De Dios, I; Manso, MA; Ramudo, L | 1 |
| Agustí, AG; Bergada, J; Ibañez, J; Jorda, R; Maimó, A; Marse, P; Raurich, JM; Togores, B | 1 |
| Lowe, D; MacKinnon, KL; Molnar, Z; Shearer, E; Watson, ID | 1 |
| Azimuddin, K; Ivatury, RR; Porter, JM; Swami, R | 1 |
| Lowe, D; Molnár, Z; Shearer, E | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Mazzon, E | 1 |
| Vaughan, D; Yanay, O; Zimmerman, JJ | 1 |
| Ariceta, J; Balén, E; Ferrer, JV; Guerrero, D; Herrera, J; Lera, JM | 1 |
| Rotstein, OD | 1 |
7 review(s) available for acetylcysteine and MODS
| Article | Year |
|---|---|
Tackle the free radicals damage in COVID-19.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Therapy, Combination; Free Radicals; Glutathione; Humans; Hydroxychloroquine; Mice; Multiple Organ Failure; NF-E2-Related Factor 2; Nitric Oxide; Orthomyxoviridae Infections; Oxidative Stress; Pandemics; Pneumonia, Viral; Reactive Oxygen Species; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
[Acute liver failure. Diagnosis and therapy].
Topics: Acetylcysteine; Chemical and Drug Induced Liver Injury; Hepatic Encephalopathy; Humans; Liver Failure, Acute; Liver Transplantation; Multiple Organ Failure; Nucleosides; Nucleotides; Organ Dysfunction Scores; Prognosis | 2013 |
N-Acetylcysteine's Role in Sepsis and Potential Benefit in Patients With Microcirculatory Derangements.
Topics: Acetylcysteine; Acidosis, Lactic; Free Radical Scavengers; Humans; Microcirculation; Mortality; Multiple Organ Failure; Regional Blood Flow; Sepsis; Vasodilation | 2018 |
Management of acute liver failure.
Topics: Acetylcysteine; Antiviral Agents; Hepatitis, Viral, Human; Humans; Liver Failure, Acute; Liver Transplantation; Multiple Organ Failure | 2009 |
Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock.
Topics: Acetylcysteine; Fluid Therapy; Hemodynamics; Humans; Intestinal Mucosa; Liver; Multiple Organ Failure; Oxygen; Respiration, Artificial; Shock, Septic; Splanchnic Circulation; Vasoconstrictor Agents | 2004 |
Deciphering the oxyradical inflammation Rosetta stone: O2*-NO*, OONO-, polymorphonuclear neutrophils, poly(ADP-ribose) synthetase, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome.
Topics: Acetylcysteine; Free Radical Scavengers; Humans; Inflammation; Multiple Organ Failure; Neutrophils; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Systemic Inflammatory Response Syndrome | 1999 |
Oxidants and antioxidant therapy.
Topics: Acetylcysteine; Antioxidants; Free Radical Scavengers; Humans; Multiple Organ Failure; Reactive Oxygen Species; Superoxide Dismutase | 2001 |
11 trial(s) available for acetylcysteine and MODS
| Article | Year |
|---|---|
Effect of N-acetylcysteine treatment on the expression of leukocyte surface markers after burn injury.
Topics: Acetylcysteine; Aged; Antigens, CD; Antioxidants; Biomarkers; Burns; Female; Flow Cytometry; Humans; Leukocytes; Male; Middle Aged; Multiple Organ Failure; Oxidative Stress; Prospective Studies | 2011 |
Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn.
Topics: Acetylcysteine; Adult; Aged; Antioxidants; Biomarkers; Burns; Catalase; Cytokines; Female; Free Radical Scavengers; Glutathione; Humans; Leukocyte Count; Male; Malondialdehyde; Middle Aged; Multiple Organ Failure; Oxidative Stress; Peroxidase; Prospective Studies; Superoxide Dismutase; Systemic Inflammatory Response Syndrome | 2012 |
[Effect of prophylactic N-acetylcysteine on postoperative organ dysfunction and inflammatory markers after major abdominal surgery for cancer. Prospective, randomized, double-blind, placebo-controlled clinical trial].
Topics: Abdominal Neoplasms; Acetylcysteine; Aged; Albuminuria; Biomarkers; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Critical Care; Double-Blind Method; Female; Humans; Inflammation; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Multiple Organ Failure; Prospective Studies; Protein Precursors; Respiration, Artificial; Treatment Outcome | 2002 |
Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial.
Topics: Abdomen; Acetylcysteine; Aged; Albuminuria; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Double-Blind Method; Female; Free Radical Scavengers; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Postoperative Period; Protein Precursors; Systemic Inflammatory Response Syndrome | 2003 |
Lack of effect of prophylactic N-acetylcysteine on postoperative organ dysfunction following major abdominal tumour surgery: a randomized, placebo-controlled, double-blinded clinical trial.
Topics: Abdominal Neoplasms; Acetylcysteine; Aged; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Multiple Organ Failure; Postoperative Complications; Treatment Failure | 2003 |
Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: results of a pilot study.
Topics: Acetylcysteine; Acute Disease; Adult; Aged; Aged, 80 and over; Albuminuria; Female; Humans; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Sepsis; Severity of Illness Index | 2005 |
Lack of effect of N-acetylcysteine treatment to ameliorate the progression of multiple organ failure.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Multiple Organ Failure; Prospective Studies | 2005 |
Effects of N-acetylcysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxia.
Topics: Acetylcysteine; Adult; Aged; Cross-Over Studies; Hemodynamics; Humans; Hydrogen-Ion Concentration; Hypoxia; Infusions, Intravenous; Middle Aged; Multiple Organ Failure; Oxygen; Oxygen Consumption; Prospective Studies | 1997 |
The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients.
Topics: Acetylcysteine; Adult; Aged; Albuminuria; Antioxidants; Cardiotonic Agents; Creatinine; Critical Illness; Double-Blind Method; Female; Free Radical Scavengers; Humans; Length of Stay; Male; Middle Aged; Multiple Organ Failure; Prospective Studies; Respiration, Artificial; Treatment Outcome | 1998 |
Antioxidant therapy in the prevention of organ dysfunction syndrome and infectious complications after trauma: early results of a prospective randomized study.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Humans; Infections; Injury Severity Score; Multiple Organ Failure; Prospective Studies; Selenium; Treatment Outcome; Vitamin E; Wounds and Injuries | 1999 |
N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study.
Topics: Acetylcysteine; Adult; Aged; APACHE; Critical Care; Double-Blind Method; Female; Free Radical Scavengers; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Time Factors | 1999 |
10 other study(ies) available for acetylcysteine and MODS
| Article | Year |
|---|---|
Fulminant
Topics: Acetylcysteine; Acidosis; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Bacillus cereus; Blood Coagulation Disorders; Blood Transfusion; Brain Diseases; Continuous Renal Replacement Therapy; Exotoxins; Fatal Outcome; Female; Foodborne Diseases; Free Radical Scavengers; Humans; Immunocompetence; Liver Failure; Multiple Organ Failure; Plasmapheresis; Renal Insufficiency; Rhabdomyolysis; Sepsis; Shock; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Whole Genome Sequencing | 2021 |
Modulation of the Redox Expression and Inflammation Response in the Critically Ill Polytrauma Patient with Thoracic Injury. Statistical Correlations between Antioxidant Therapy.
Topics: Abbreviated Injury Scale; Acetylcysteine; Adult; Aged; Antioxidants; Ascorbic Acid; Critical Illness; Female; Humans; Incidence; Inflammation; Injury Severity Score; Length of Stay; Male; Middle Aged; Multiple Organ Failure; Multiple Trauma; Oxidation-Reduction; Oxidative Stress; Respiration, Artificial; Retrospective Studies; Sepsis; Thiamine; Thoracic Injuries | 2016 |
Effects of reactive oxygen species scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Cytokines; Free Radical Scavengers; Heart; Inflammation; Kidney; Liver; Lung; Male; Mice; Multiple Organ Failure; Myocardium; Oxygen; Reactive Oxygen Species; Sepsis; Thiourea; Zymosan | 2010 |
Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress.
Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Deferoxamine; Disease Models, Animal; Kidney; Lung; Male; Multiple Organ Failure; Neutrophil Infiltration; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Sepsis; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Urea | 2011 |
When will we learn?
Topics: Acetylcysteine; Critical Care; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Multiple Organ Failure; NF-kappa B; Randomized Controlled Trials as Topic; Systemic Inflammatory Response Syndrome; Treatment Failure | 2004 |
Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats.
Topics: Acetylcysteine; Animals; Blood Pressure; Cytokines; Drug Administration Schedule; Free Radical Scavengers; Heart; Heart Rate; Kidney; Kidney Function Tests; Lipopolysaccharides; Liver; Liver Function Tests; Male; Multiple Organ Failure; Myocardium; Rats; Rats, Inbred WKY; Shock, Septic | 2006 |
Death from paracetamol overdose despite appropriate treatment with N-acetylcysteine.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Drug Overdose; Fatal Outcome; Free Radical Scavengers; Humans; Male; Middle Aged; Multiple Organ Failure | 2007 |
Extrapancreatic organ impairment during acute pancreatitis induced by bile-pancreatic duct obstruction. Effect of N-acetylcysteine.
Topics: Acetylcysteine; Acute Disease; Alanine Transaminase; Amylases; Animals; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cholestasis; Creatinine; L-Lactate Dehydrogenase; Ligation; Liver; Lung; Male; Models, Animal; Multiple Organ Failure; Pancreas; Pancreatitis; Peroxidase; Rats; Rats, Wistar; Time Factors; Treatment Outcome | 2007 |
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Leukocyte Count; Male; Multiple Organ Failure; Nitrates; Nitric Oxide; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Septic; Survival Analysis; Time Factors; Zymosan | 1999 |
Prevention by somatostatine and N-acetylcisteine of multiorgan failure mediated by oxidative stress after intestinal ischemia.
Topics: Acetylcysteine; Adenosine Triphosphate; Allopurinol; Animals; Glutathione; Heart; Intestine, Small; Ischemia; Liver; Lung; Malondialdehyde; Mesenteric Arteries; Multiple Organ Failure; Myocardium; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Somatostatin | 1999 |